# Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

> **NCT00309478** · PHASE3 · COMPLETED · sponsor: **Austrian Breast & Colorectal Cancer Study Group** · enrollment: 1099 (actual)

## Conditions studied

- Early-stage Breast Cancer

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Methotrexate
- **DRUG:** Fluorouracil implant
- **DRUG:** Goserelin
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00309478
- **Lead sponsor:** Austrian Breast & Colorectal Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-12
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 1099 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309478, "Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00309478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*